Could You Have COPD Without Knowing It?
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that affects millions worldwide, causing…
Articles
Impavido: A Lifesaving Drug In The Fight Against Leishmaniasis Faces Global Access Challenges
In a world still grappling with neglected tropical diseases, Impavido (generic name: miltefosine) remains one…
Imdelltra (Tarlatamab-Dlle): A Breakthrough In Treating Extensive-Stage Small Cell Lung Cancer
Imdelltra™ (tarlatamab-dlle) represents a significant advancement in the treatment of extensive-stage small cell lung cancer…
Comments Off On Pfizer’s Hympavzi Approved By FDA For Use In Treating Hemophilia Symptoms
HYMPAVZI is the first and only anti-tissue factor pathway inhibitor (anti-TFPI) approved in the U.S.…
Fampyra (Fampridine): Enhancing Mobility In Multiple Sclerosis Patients
Fampyra, known generically as fampridine or 4-aminopyridine, is an oral medication approved to improve walking…
Is Hepatitis C Curable? Breaking Down the Myths
Hepatitis C (HCV) is a viral infection that primarily affects the liver, leading to inflammation…
Fetroja (Cefiderocol): A Breakthrough In Combating Multidrug-Resistant Gram-Negative Infections
In the ongoing battle against antimicrobial resistance, Fetroja (cefiderocol) has emerged as a promising solution…
Antizol (Fomepizole): A Critical Antidote In Toxicology
Antizol, the brand name for fomepizole, is an essential antidote used in the treatment of…
Elrexfio A New Hope For Relapsed Or Refractory Multiple Myeloma Patients
In a significant advancement for multiple myeloma treatment, the U.S. Food and Drug Administration (FDA)…
Dupixent’s Expanding Therapeutic Reach And Market Success In 2025
In 2025, Dupixent (dupilumab), developed by Sanofi and Regeneron, continues to solidify its position as…